Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Hemostemix Inc (HEM)

TSXV
Symbol
Exchange
Currency
HEMTSXVCAD
HEMCBOE CanadaCAD
Currency in CAD
Disclaimer
0.0400
0.0000(0.00%)
Delayed Data

HEM Comments

The negative impact on the stock market stemming from $HEM's poor services has been a source of disappointment for investors who have suffered losses. I also suffered losses.
Shareholders of $HEM face a challenging situation as the company's profitability remains elusive, casting shadows of uncertainty over the company's future.
$HEM's stock continued to underperform, with a 15% decrease to $0.085 on the previous trading day, resulting in financial losses for investors.
$HEM continues to struggle financially, with no signs of profitability in sight. Shareholders are left with uncertainty about the company's future.
The technical analysis of the stock $HEM shows that it is trading at an affordable price, with more than 81 million outstanding shares. As a healthcare stock, it will be a good option for long-term investors .
This stock has proven to be a trustworthy pick for investors seeking consistent, long-term gains. Its steadiness has made it an attractive option among investors, as seen by the high number of 65K shares traded yesterday.
$HEM has consistently delivered a good return. The company has maintained financial stability and has the potential to continue bolstering its market share in the coming months.
The company has a market capitalization of $12.97 million and has been gaining popularity among investors due to its low-cost offering and potential for future growth. HEM has a diversified portfolio of investments and a well-managed balance sheet, which gives investors confidence in the company's long-term stability and future prospects.
Hemostemix is looking to expand and has been conducting interviews for a new Executive VP of Business Development. The stock is trading at a pocket friendly price over TSX-V .
The technical analysis of the stock $HEM shows that it is trading at an affordable price, with more than 81 million outstanding shares. As a healthcare stock, it looks quite profitable for long-term investors.
The stock $HEM is trading over TSX-V with a market cap. of 12.7million+ , the stock is peforming steadily this week and trading at a reasonable price that will attract the investors
Hemostemix $HEM is looking for an Executive Vice President of Business Development. The successful candidate will be responsible for selling convertible debentures to raise funds, rolling up podiatry clinics in the USA, and providing direction for potential clinic acquisitions globally.
Hemostemix inc. $HEM is trading at a pocket friendly price over TSX-V .(0.175) and attracting the investors by its mission vision and good initiatives .
$HEM is the best stock to diversify your portfolio with minimize the risk of loss. The shares are the least volatile, with 50 days average volume of 75k.
The importance of HEM is derived from Hemostemix's development of a therapy for critical limb ischemia, which acts as a gateway indication for ischemic disorders, including peripheral arterial and cardiovascular diseases.
Is there s stock split on HEM
this is gonna be $1 all day
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.